No Data
No Data
Jianghai Securities: The enthusiasm for DLL3 drug development is increasing, and the prospects for domestic ADC drugs are broad.
As the recognition of domestic Innovative Drugs in the international market continues to rise, companies with potential for international cooperation and expansion are expected to further explore market opportunities.
Hong Kong stocks movement | ZAI LAB (09688) rose over 5%. Institutions are bullish on its commercialization and innovative research and development, initially rating it as 'Buy'.
ZAI LAB (09688) rose more than 5%, as of the time of writing, an increase of 5.01%, priced at 20.35 Hong Kong dollars, with a transaction amount of 51.4273 million Hong Kong dollars.
Zai Lab Secures 300 Million Yuan Debt Facility
Express News | Zai Lab Ltd: Zai Lab Shanghai Entered Into Working Capital Loan Contract With BOCOM Regarding Revolving Credit Facility of up to RMB300 Mln
Insider Sale: See Remarks of $ZLAB (ZLAB) Sells 7,583 Shares
Asian Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading